Marten Brienen is an Associate Professor at Oklahoma State University, affiliated with OSU Global. His career spans multiple disciplines including Political Science, Global Studies, and Fire and Emergency Management Administration at R1 institutions. He is a historian of twentieth-century Latin America with interdisciplinary expertise shaped by diverse teaching experiences. PhD in Social and Political Sciences from University of Amsterdam (2011) Currently teaches Global Crisis Management, Complex Emergencies, and advanced research courses His research focuses on weak institutions and their consequences, such as: Drug trade dynamics in Bolivia, Peru, and Colombia Resource populism and energy security Communal violence and prison overpopulation Corruption and disaster response failures Article trends show evolving expertise from Latin American politics (2015-2019) to pandemic trade analysis (2022-2024) and synthetic opioid studies (2025). Scientific recognition includes: Hargis Fellowship (2023) Two Outstanding Research Awards (2017, 2018) He supervises graduate research and advises on academic integrity, while engaging in media outreach about Latin American political developments.
Chima D Ndumele is an Associate Professor of Public Health (Health Policy) at the Yale School of Public Health and a Professor at the Institution for Social and Policy Studies . His research focuses on Medicaid policy, health equity, and safety-net healthcare systems, with a particular emphasis on how policy changes affect vulnerable populations and chronic disease management. Doctorate from Brown University School of Public Health (2013) ORCID: 0000-0002-4887-0043 Key collaborations with Yale researchers including Jacob Wallace, Harlan Krumholz, and Yuan Lu Dr. Ndumele’s recent publications examine Medicaid eligibility procedural denials, SNAP work requirements, racial disparities in pandemic mortality, and alternative payment models in safety-net hospitals. His work integrates health policy analysis with empirical studies on insurance coverage effects and socioeconomic determinants of health outcomes. Current affiliations include the Diabetes Research Center , SCALE Medicaid Lab , and multiple roles in health policy research. He contributes to the JAMA Health Forum , JAMA Internal Medicine , and Health Affairs , focusing on equity in healthcare access and delivery.
Luke Davis, MD is an Associate Professor of Epidemiology (Microbial Diseases) and Medicine (Pulmonary, Critical Care & Sleep Medicine) at Yale School of Public Health , with affiliated roles at Yale Institute for Global Health and Yale Medicine . He directs the Implementation Science Track and leads international research programs focused on tuberculosis (TB) and HIV. Education : MD (Vanderbilt University), AB (Princeton University), MAS in Clinical Research (University of California San Francisco), Fellowship in Pulmonary & Critical Care (UCSF) Clinical Practice : Attending physician at Yale-New Haven Hospital's Medical ICU and Winchester TB Clinic Research Focus : Implementation science strategies to improve TB and HIV diagnosis, treatment, and stigma reduction across Uganda, South Africa, Colombia, Mongolia, and the United States. Key projects include: Uganda : HIV-TB household contact investigations, gene-expression profiling for biomarker development, Xpert MTB Ultra evaluation Colombia : Cali TB contact investigation using design thinking Mongolia : Zero TB Initiative quality assessments Connecticut : COVID-19 contact tracing analysis Publication Trends (15 most recent): 50% focus on TB-HIV coinfection and implementation trials in Sub-Saharan Africa 30% on digital health technologies for infectious disease management 20% on geriatric care innovations and medical education Collaborations : Frequent co-authors include Sheela Shenoi , Salome Charalambous , and Donna Spiegelman . Research spans biomedical engineering integration, stigma reduction frameworks, and quality improvement methodologies.
Anna-Karin Wikström is a Professor of Obstetrics and Gynecology and Senior Physician at the Department of Women's and Children's Health, Uppsala University. She previously served as Professor of Obstetrics and Gynecology at Karolinska Institutet from 2016-2017. Her extensive clinical experience spans over two decades in obstetrics and gynecology, with specialized expertise in high-risk pregnancies. Her educational background includes medical studies at Karolinska Institutet (1985-1991), becoming a specialist in obstetrics and gynecology in 2001, earning her PhD from Uppsala University in 2006, and completing a post-doc at Karolinska Institutet's Clinical Epidemiology Unit (2009-2011). She became an associate professor at Uppsala University in 2011 before advancing to full professor in 2017. Professor Wikström's research primarily focuses on preeclampsia, where she leads major initiatives including IMPACT (a national study on preeclampsia prediction) and UP-MOST (a biobank for preeclampsia research). Her work spans cardiovascular effects of preeclampsia, brain imaging studies in affected women, and register-based epidemiological research. Beyond preeclampsia, her research interests include pregnancy in women with congenital heart disease, myasthenia gravis, and other chronic conditions. Her extensive publication record demonstrates expertise in maternal-fetal medicine with particular emphasis on prediction models for adverse pregnancy outcomes and understanding long-term health implications. Her recent publications reveal a strong focus on neurological consequences of hypertensive disorders in pregnancy, maternal physical activity effects on fetal outcomes, and innovative screening approaches for pregnancy complications. The research frequently utilizes large Swedish population-based registers, contributing significantly to evidence-based obstetric care in the Nordic region. Professor Wikström actively contributes to clinical research that directly impacts patient care, particularly in preeclampsia screening and prevention. Her work often takes a Nordic perspective, informing regional guidelines and practices. She collaborates extensively across disciplines including cardiology, neurology, and epidemiology to advance understanding of pregnancy complications and their long-term consequences.
Bo Malmberg is a Professor at the Department of Human Geography, Stockholm University, where he has been conducting research for over 30 years. His work spans multiple subfields of Human Geography, with a focus on Population Geography, Migration, and GIS. He is actively involved in several major research projects examining spatial polarization, social cohesion, and migrant trajectories in Sweden. Professor Malmberg's research covers four main subfields of Human Geography: Economic Geography, Population Geography, Urban Geography (with particular focus on residential segregation and neighborhood effects), and GIS and Remote Sensing. His early work examined multi-plant firms and operational decisions, while later research explored the relationship between population age structure and economic growth. He has developed innovative approaches to measuring segregation using individualized scalable neighborhoods, which avoids the modifiable areal unit problem associated with traditional segregation measurement techniques. His recent publications demonstrate a strong focus on life-course trajectories, spatial segregation, and the socio-spatial dimensions of health outcomes including COVID-19. His work frequently employs register data from Sweden to examine long-term demographic patterns and their relationship to economic and social outcomes. A significant portion of his recent research examines educational segregation, school choice, and the relationship between residential patterns and educational attainment. Professor Malmberg has collaborated extensively with colleagues including Eva Andersson and Karen Haandrikman on projects examining segregation, migration, and social cohesion. His work has been published in leading geography and social science journals including Environment and Planning A, Journal of Urban Affairs, Urban Studies, and Annals of the Association of American Geographers.
Mette Kalager is a Professor at the Department of Health Management and Health Economics within the Faculty of Medicine at the University of Oslo. Her research focuses on cancer epidemiology, colorectal cancer screening, and health economics, with extensive contributions to understanding overdiagnosis in cancer screening and optimizing colonoscopy practices. She maintains an active research program with numerous high-impact publications in leading medical journals. Her primary research interests center on cancer screening effectiveness, particularly in colorectal cancer prevention. Dr. Kalager's work explores the balance between benefits and harms of screening programs, with special attention to overdiagnosis and the development of risk prediction models. She has made significant contributions to understanding the relationship between adenoma detection rates and subsequent cancer risk, as well as the impact of artificial intelligence on colonoscopy quality. Her research portfolio demonstrates a consistent focus on evidence-based approaches to cancer prevention and healthcare decision making. Analysis of her recent publications reveals a strong emphasis on methodological approaches to evaluating cancer screening programs, with increasing integration of artificial intelligence applications in endoscopy. Her work spans epidemiological modeling, clinical trials, systematic reviews, and health policy analysis, consistently addressing critical questions about the effectiveness and efficiency of cancer prevention strategies. The research demonstrates a trajectory toward more personalized approaches to cancer screening based on individual risk assessment. Dr. Kalager leads or participates in multiple significant research projects including COLONIZE (focusing on Clostridioides difficile infection treatment), EPoS (European Polyp Surveillance), EndoBRAIN International, I-SCAN (Scandinavian study on IBD and cancer), NordICC (Nordic-European study on colorectal cancer prevention), and several others addressing gastrointestinal diseases, cancer risk, and healthcare interventions. Her collaborative approach is evident through extensive co-authorship with researchers across Europe and beyond.
Susan L. Davis, Pharm.D., is Clinical Professor of Pharmacy Practice and Associate Dean for Pharmacy at Wayne State University’s Eugene Applebaum College of Pharmacy and Health Sciences, while simultaneously serving as Infectious Diseases Pharmacy Specialist at Henry Ford Hospital. Education & Training Doctor of Pharmacy, University of Michigan, 2002 Pharmacy Practice Residency, Detroit Receiving Hospital, 2003 Fellowship in Infectious Diseases Outcomes Research, Wayne State University, 2005 Research Interests Dr. Davis is internationally recognized for work in antimicrobial stewardship , epidemiology of resistant organisms , and economic outcomes of anti-infective therapy . Her investigations focus on optimizing antibiotic exposure, preventing resistance, and improving clinical outcomes in serious infections such as MRSA bacteremia, carbapenem-resistant Gram-negative pathogens, and Clostridioides difficile . Publication Themes Across more than 150 publications, her recent work (2019-2025) illustrates a clear trajectory toward pragmatic stewardship interventions—evaluating IV-to-PO switch strategies, real-world effectiveness of newer agents (ceftolozane-tazobactam, eravacycline, meropenem-vaborbactam), and pharmacist-led transitions-of-care models. Multiple multicenter cohort studies and randomized trials emphasize safety endpoints such as vancomycin nephrotoxicity and antifungal discontinuation guided by rapid diagnostics. Awards & Honors Wayne State University Board of Governors Faculty Recognition Award (2021) EACPHS Research Excellence Award (2015) Society of Infectious Diseases Pharmacists Outstanding Clinical Practice Award (2012) ASHP Foundation New Preceptor of the Year (2008) Roche & Henry Ford Preceptor of the Year distinctions (multiple years) Teaching & Mentorship Dr. Davis directs the infectious-disease pharmacotherapy sequence (PHA 5215) and precepts Pharm.D. candidates, residents, and fellows. She has built an extensive mentorship network, serving as primary research adviser for numerous Pharm.D. residents and graduate students whose projects feed into national MAD-ID research initiatives. Clinical & Administrative Roles At Henry Ford Hospital she leads antimicrobial stewardship rounds, while at Wayne State she oversees curriculum, accreditation, and strategic initiatives as Associate Dean. Her dual appointments integrate bench-to-bedside research with policy-level stewardship program development.
Dr. Craig F. Purchase is a Professor of Biology in the Department of Biology within Memorial University's Faculty of Science. His research focuses on evolutionary ecology of fishes, particularly salmonid reproduction, hybridization dynamics, and cryptic female choice mechanisms. Leading multiple active field teams (Team Salmon, Team Trout, Team Redfish), he conducts intensive research on Atlantic salmon, brown trout, and Acadian redfish in Newfoundland ecosystems including Gros Morne National Park and Bonne Bay fjord. His research program integrates field ecology with laboratory experiments to investigate: Sperm competition and cryptic female choice in external fertilizers Hybridization barriers between invasive brown trout and native Atlantic salmon Environmental impacts on reproductive physiology Senescence patterns in long-lived fish species Conservation strategies for threatened salmonid populations Recent publications reveal strong focus on reproductive fluid dynamics, hybridization prevention mechanisms, and climate change impacts on salmonid life histories. His work shows particular expertise in ovarian fluid rheology, sperm-egg interactions, and landscape-level invasion dynamics. Scientific recognition includes: Election as Vice-President (2020-2021) and President (2022-2023) of the Canadian Aquatic Resources Section (CARS) of the American Fisheries Society Multiple NSERC-funded projects supporting undergraduate and graduate research Collaborations with international institutions in Sweden, Norway, Australia, and USA He actively mentors numerous graduate and undergraduate students through field-intensive projects, securing substantial grants from Atlantic Salmon Conservation Foundation and Fisheries & Oceans Canada. His lab maintains strong partnerships with Parks Canada, ERMA (Eastern Regional Model Aquaculture), and the Salmonid Association of Eastern Newfoundland.
Clas-Håkan Nygård is a senior researcher at the University of Tampere 's School of Health Sciences, Department of Public Health, with an academic career spanning over four decades since 1981. His work focuses on occupational epidemiology, work ability sustainability, and aging workforce dynamics through extensive longitudinal cohort studies. Key Research Areas Long-term effects of workplace conditions on aging Stress and burnout management in education/industrial sectors Biomechanical risk factors for musculoskeletal disorders Population health metrics and WHO/ILO burden of disease estimation Notable Contributions Developed GUHA data mining applications for premature death prediction Conducted 28-year cohort studies linking midlife work conditions to late-life disability Created sustainable employability indices for older workers Academic Engagement Chaired ICOH 2012 World Congress sessions Reviewed for journals like International Journal of Epidemiology Evaluated over 18 doctoral dissertations
Christian Wirth is a Professor at Leipzig University, where he serves as Director of the Botanical Garden and heads the Special Botany and Functional Biodiversity Group. He is also the founding director of the German Centre for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig. His research integrates botany and plant ecology with species conservation, focusing on biodiversity-ecosystem functioning relationships in terrestrial ecosystems. Education includes: Diploma in Biology (1996) from University of Bayreuth PhD (summa cum laude, 2000) from University of Bayreuth Wirth's research examines how natural and human-induced biodiversity changes affect ecosystem processes like carbon storage, water consumption, and energy balance. His pioneering work includes developing trait-based approaches (TRY database) and investigating climate change impacts on forests. Current projects focus on forest conservation, functional diversity, and biogeochemical cycling using advanced facilities like the Leipzig Auwaldkran canopy crane and ARBOfun research arboretum. His publications emphasize biodiversity-ecosystem functioning relationships, with recent work exploring drought resilience in forests, root trait economics, soil microbial interactions, and remote sensing applications. Research consistently demonstrates how plant traits and community composition mediate ecosystem responses to global change stressors. Major research projects include: NFDI4BioDiversität (2021-2025): Biodiversity and environmental data infrastructure Faktencheck Artenvielfalt (2021-2024): National biodiversity assessment Quantifizierung der Kommunikationsdienstleistung durch Biodiversität (2017-2021) Wirth leads the Special Botany group investigating functional biodiversity significance and directs field research facilities including the Leipzig Auwaldkran. His team collaborates extensively within iDiv's interdisciplinary research framework.
Daniel Kneeshaw is a Professor in the Department of Biological Sciences at the University of Quebec in Montreal (UQAM), where he holds the UQAM Strategic Research Chair on the resilience and vulnerabilities of temperate and boreal forests to climate change. He is a Regular Member of the Center for Forest Ecology (CEF) and has been actively contributing to forest ecology research since joining UQAM in 2001 after serving as a researcher at the Forest Research Branch of the Quebec Ministry of Natural Resources. His educational background includes a Post-doctorate in forestry sciences (1999, Laval University), Ph.D. in Environmental Sciences (1997, UQAM), M.Sc. in Forest Ecology (1992, University of British Columbia), and B.Sc. in Forestry (1989, University of Toronto). Before his academic career, he worked in softwood forests in Manitoba and British Columbia. Dr. Kneeshaw's research focuses on sustainable forest management tools, mortality and population dynamics in forest ecosystems, and the dynamics of forest gaps in maintaining old-growth forests. His work aims to develop and integrate indicators of sustainable forest management by better understanding forest dynamics, particularly in advanced development stages, tree mortality and regeneration, and competition in gaps. He employs modeling approaches to assess ecosystem responses to different management strategies across multiple spatial and temporal scales. His recent publications demonstrate a strong focus on climate change impacts on boreal forests, tree physiology in urban environments, forest insect outbreaks (particularly spruce budworm), and biogeochemical processes in forest ecosystems. His research spans from fundamental forest ecology to applied management solutions, with a growing emphasis on climate change adaptation and resilience. Prix de la Faculté des sciences de l'UQAM 2024 - Prix de la recherche - Professeur – volet carrière Prix de la ministre de l'éducation, du loisir et du sport for the book Aménagement écosystémique en forêt boréale (2009) Dr. Kneeshaw has supervised an extensive number of graduate students (over 50 Master's and PhD students listed) and has collaborated with numerous researchers across Canada and internationally. His work has been supported by various grants, including NSERC funding for his postdoctoral research and ongoing projects related to forest dynamics and climate change. He has contributed significantly to developing ecosystem-based management approaches that mimic natural disturbance regimes in boreal forests. His laboratory focuses on understanding forest dynamics at multiple scales, from tree-level physiological processes to landscape-level patterns. His team employs a range of methodologies including field measurements, dendrochronology, remote sensing (particularly LiDAR), and ecosystem modeling to address complex questions about forest resilience and sustainability in the face of climate change and other disturbances.
Karin M Best serves as an Assistant Adjunct Professor in the Department of Psychiatry and Biobehavioral Sciences at the David Geffen School of Medicine, University of California, Los Angeles (UCLA). Her academic career spans nearly two decades with consistent scholarly output from 2004 through 2022, demonstrating sustained engagement in child and adolescent psychiatric research and education. Dr. Best's research program focuses on critical areas in psychiatric medicine with particular emphasis on child and adolescent populations. Her work spans several interconnected domains: psychotherapy competencies and training models (particularly the MAP Curriculum); mental health service delivery for children with autism spectrum disorder; neurobiological aspects of developmental disorders like ADHD; and interventions for vulnerable populations including HIV-affected families. Her research consistently bridges clinical practice and academic scholarship, with strong emphasis on evidence-based approaches and practical implementation in real-world settings. Analysis of Dr. Best's publication history reveals an evolving research trajectory that maintains consistent focus on improving mental health outcomes for children and adolescents. Her recent work (2021-2022) emphasizes curriculum development for psychotherapy training and implementation science in community mental health settings. Earlier work (2012-2014) examined HIV-affected families and medical education models, while her foundational research (2004) investigated long-term outcomes of adolescent psychiatric hospitalization. Across her career, she has maintained focus on translating research into practice while addressing the needs of vulnerable pediatric populations. Dr. Best maintains an extensive collaborative network across the University of California system, with significant co-authorship ties to researchers at UCSD (particularly Lauren Brookman-Frazee), UCLA colleagues including Shantanu Joshi and Sheryl Kataoka Endo, and USC researchers like Eric Rice. Her work has demonstrated practical impact beyond academia, with one publication referenced in policy sources and multiple papers garnering substantial academic readership on platforms like Mendeley. Her research activities appear integrated with broader initiatives at UCLA's Semel Institute for Neuroscience and Human Behavior, though specific lab affiliations aren't explicitly detailed in the available information. Her work contributes to ongoing efforts to improve mental health service delivery systems, particularly for children and families facing complex challenges including developmental disorders and chronic health conditions.
Ponni Perumalswami, MD, MsCR, serves as Clinical Professor of Internal Medicine and Clinical Associate Professor of Psychiatry at the University of Michigan Medical School. She is an active Center Member at both the Institute for Healthcare Policy and Innovation and the MExperts-Opioid Research Institute, with demonstrated commitment to mentoring and advancing healthcare through research and policy. Her work bridges clinical practice, population health, and health equity initiatives. Her research focuses on liver disease pathogenesis and management, particularly cirrhosis, viral hepatitis, and alcohol-associated liver disease, with strong emphasis on social determinants of health, health disparities, and vulnerable populations including Veterans and minority communities. She investigates how neighborhood socioeconomic factors, rurality, and systemic barriers impact disease progression and mortality in diabetes and liver conditions, employing population health approaches and quality improvement frameworks. Analysis of her 2025 publications reveals consistent thematic focus on health equity in liver disease, with major contributions in Veterans' healthcare systems, Asian American community engagement, and pharmacological interventions for alcohol use disorder. Her work spans clinical epidemiology, quality improvement, and health services research, frequently published in high-impact journals including Gastroenterology and Hepatology. Dr. Perumalswami's institutional affiliations with policy-focused research centers demonstrate her integration of clinical expertise with healthcare innovation, particularly through the Institute for Healthcare Policy and Innovation where she contributes to evidence-based policy development and the MExperts-Opioid Research Institute where she addresses substance use disorders in liver disease contexts.
Dr. Inga Effert serves as an Academic Councillor at the Department of Protestant Theology within the Faculty of Humanities and Cultural Studies at the University of Wuppertal, a position she has held since April 2017. Her work focuses on religious education didactics for primary schools, with office hours coordinated through the university's Moodle platform in room O.10.04. Her academic background includes: Born 1985 in Lüdenscheid 2005-2011: Protestant Religious Education and German Studies at University of Paderborn 2011: First State Examination for Teaching 2011-2015: Doctoral studies at University of Paderborn April 2015: Doctorate on 'Religion – Inclusion – Values' 2014-2016: Traineeship in Protestant Religious Education May 2016: Second State Examination for Primary School Teaching Dr. Effert's research centers on inclusion strategies in religious education, value-based pedagogy, and burnout prevention within theological frameworks. She develops practical materials bridging biblical narratives with contemporary educational challenges, particularly for primary school contexts. Her scholarship examines how Protestant confession-based schools implement inclusion through value anchoring in school culture. Analysis of her 13 publications (2015-2021) reveals consistent focus on inclusive religious education, with evolving emphasis from structural school policies (2015) to practical classroom resources (2017-2019) and interdisciplinary theological explorations (2021 music study). The work demonstrates strong integration of empirical school analysis with creative pedagogical development, particularly through the 'RU für morgen' series. Dr. Effert maintains active scholarly engagement through co-authored teaching materials with Gunther vom Stein and digital content including YouTube theological discussions. Her consultation services operate through university digital platforms with individually arranged appointments.
Jason Abaluck is a Professor of Economics at Yale School of Management, specializing in health economics and behavioral economics. His research focuses on consumer choice in health insurance markets, particularly Medicare Part D, and the effects of health interventions. Abaluck has led major research initiatives including a cluster randomized trial in Bangladesh involving 350,000 people to assess the impact of community masking on COVID-19 transmission. Abaluck's research interests span health economics, insurance markets, behavioral economics, and public health interventions. His work examines how consumers make decisions in complex health insurance markets, with a particular focus on Medicare Part D. He investigates choice inconsistencies, welfare implications, and potential policy solutions to improve decision-making. His research on mask-wearing during the pandemic demonstrated significant reductions in COVID transmission, particularly among vulnerable elderly populations. Analysis of Abaluck's publications reveals a consistent focus on healthcare decision-making across multiple contexts. His work spans theoretical modeling of consumer choice, empirical analysis of insurance markets, and field experiments testing public health interventions. Key themes include the impact of information on decision quality, the welfare consequences of choice inconsistencies, and the design of market structures to improve outcomes. Abaluck's scientific contributions have been recognized with several prestigious awards: 2023 Top 10 Clinical Research Award for his work on community masking during the pandemic 2017 NIHCM Honorable Mention for the Best Paper in Health Economics 2012 NIHCM Winner for the Best Paper in Health Economics Abaluck has secured significant research funding for projects including 'Differential Mortality in Medicare Advantage,' 'Mortality Effects of Health Insurance Networks and Providers,' and 'HEARTSPOT: Implementation and Rigorous Evaluation of a Machine Learning System to Aid Decision-Making in the Emergency Department.' His current work includes large-scale cluster randomized trials in multiple countries examining vaccination rates and the impact of trial representativeness on doctor treatment decisions. Abaluck leads collaborative research teams involving dozens of researchers from Yale, Stanford, Berkeley, and other institutions. His Bangladesh mask-wearing study, for example, involved coordination across multiple organizations and 600 villages. His work often bridges economics, public health, and clinical medicine, reflecting his interdisciplinary approach to solving complex healthcare problems.
